233 related articles for article (PubMed ID: 1360505)
1. Plasma protein binding of quinine: binding to human serum albumin, alpha 1-acid glycoprotein and plasma from patients with malaria.
Wanwimolruk S; Denton JR
J Pharm Pharmacol; 1992 Oct; 44(10):806-11. PubMed ID: 1360505
[TBL] [Abstract][Full Text] [Related]
2. Alpha 1-acid glycoprotein (orosomucoid) and plasma protein binding of quinine in falciparum malaria.
Silamut K; Molunto P; Ho M; Davis TM; White NJ
Br J Clin Pharmacol; 1991 Sep; 32(3):311-5. PubMed ID: 1777366
[TBL] [Abstract][Full Text] [Related]
3. Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer.
Calvo R; Jiménez RM; Trocóniz IF; Suárez E; Gonzalo A; Lucero ML; Raczka E; Orjales A
Cancer Chemother Pharmacol; 1998; 42(5):418-22. PubMed ID: 9771958
[TBL] [Abstract][Full Text] [Related]
4. Effect of Plasmodium falciparum malaria infection on the plasma concentration of alpha 1-acid glycoprotein and the binding of quinine in Malawian children.
Mansor SM; Molyneux ME; Taylor TE; Ward SA; Wirima JJ; Edwards G
Br J Clin Pharmacol; 1991 Sep; 32(3):317-21. PubMed ID: 1777367
[TBL] [Abstract][Full Text] [Related]
5. Differences in the binding of quinine and quinidine to plasma proteins.
Mihaly GW; Ching MS; Klejn MB; Paull J; Smallwood RA
Br J Clin Pharmacol; 1987 Dec; 24(6):769-74. PubMed ID: 3440096
[TBL] [Abstract][Full Text] [Related]
6. Relationship between alpha 1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyldisopyramide.
Bredesen JE; Kierulf P
Br J Clin Pharmacol; 1984 Nov; 18(5):779-84. PubMed ID: 6508986
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of serum protein binding of felodipine.
Valle M; Esteban M; Rodríguez-Sasiaín JM; Calvo R; Aguirre C
Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):73-88. PubMed ID: 8948016
[TBL] [Abstract][Full Text] [Related]
8. Lidocaine plasma protein binding.
Routledge PA; Barchowsky A; Bjornsson TD; Kitchell BB; Shand DG
Clin Pharmacol Ther; 1980 Mar; 27(3):347-51. PubMed ID: 7357791
[TBL] [Abstract][Full Text] [Related]
9. Binding of prazosin and propranolol at variable alpha 1-acid glycoprotein and albumin concentrations.
Sager G; Jaeger R; Little C
Br J Clin Pharmacol; 1989 Feb; 27(2):229-34. PubMed ID: 2713217
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting serum protein binding of cocaine in humans.
Parker RB; Williams CL; Laizure SC; Lima JJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):605-10. PubMed ID: 7473145
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective binding of propranolol to human plasma, alpha 1-acid glycoprotein, and albumin.
Walle UK; Walle T; Bai SA; Olanoff LS
Clin Pharmacol Ther; 1983 Dec; 34(6):718-23. PubMed ID: 6641085
[TBL] [Abstract][Full Text] [Related]
12. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
[TBL] [Abstract][Full Text] [Related]
13. Determinants of the plasma protein binding of theophylline in health.
Buss D; Leopold D; Smith AP; Routledge PA
Br J Clin Pharmacol; 1983 Apr; 15(4):399-405. PubMed ID: 6849774
[TBL] [Abstract][Full Text] [Related]
14. Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.
Zini R; Morin D; Salvadori C; Tillement JP
Br J Clin Pharmacol; 1990 Jan; 29(1):9-18. PubMed ID: 2297464
[TBL] [Abstract][Full Text] [Related]
15. The plasma protein binding of metoclopramide in health and renal disease.
Webb D; Buss DC; Fifield R; Bateman DN; Routledge PA
Br J Clin Pharmacol; 1986 Mar; 21(3):334-6. PubMed ID: 3964535
[TBL] [Abstract][Full Text] [Related]
16. Contribution of plasma proteins, albumin and alpha 1-acid glycoprotein, to pharmacokinetics of a multi-targeted receptor tyrosine kinase inhibitor, sunitinib, in analbuminemic rats.
Toyama Y; Ueyama J; Nomura H; Tsukiyama I; Saito H; Hisada T; Matsuura K; Hasegawa T
Anticancer Res; 2014 May; 34(5):2283-9. PubMed ID: 24778032
[TBL] [Abstract][Full Text] [Related]
17. The influence of alpha 1-acid glycoprotein on quinine and quinidine disposition in the rat isolated perfused liver preparation.
Mansor SM; Ward SA; Edwards G; Hoaksey PE; Breckenridge AM
J Pharm Pharmacol; 1991 Sep; 43(9):650-4. PubMed ID: 1685525
[TBL] [Abstract][Full Text] [Related]
18. Determinants of carbamazepine and carbamazepine 10,11-epoxide binding to serum protein, albumin and alpha 1-acid glycoprotein.
MacKichan JJ; Zola EM
Br J Clin Pharmacol; 1984 Oct; 18(4):487-93. PubMed ID: 6487490
[TBL] [Abstract][Full Text] [Related]
19. The safety and kinetics of intramuscular quinine in Malawian children with moderately severe falciparum malaria.
Mansor SM; Taylor TE; McGrath CS; Edwards G; Ward SA; Wirima JJ; Molyneux ME
Trans R Soc Trop Med Hyg; 1990; 84(4):482-7. PubMed ID: 2091333
[TBL] [Abstract][Full Text] [Related]
20. Binding of prazosin to alpha 1-acid glycoprotein and albumin: effect of protein purity and concentrations.
Sager G; Jaeger R; Little C
Pharmacol Toxicol; 1989 Apr; 64(4):365-8. PubMed ID: 2748545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
